Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

ALRN-6924 may prevent hair loss caused by chemotherapy.

Diphencyprone treatment for alopecia areata can cause vitiligo in some patients.

Dupilumab is effective and safe for treating moderate-to-severe atopic dermatitis in adolescents.

Dupilumab effectively treated severe alopecia areata in a child.

PROTACs have become a breakthrough in medicine by effectively targeting and degrading specific proteins to treat diseases.

The cooling system effectively and safely treats benign pigmented lesions in Asians.

DOPE:DOPC liposomes can improve targeted cancer drug delivery, reducing side effects and increasing effectiveness.

APCs may improve hair density in cicatricial alopecia but effects may not last long.

Etanercept effectively treated a severe skin condition when other treatments failed.

20(S)-Protopanaxadiol-aglycone may help prevent and treat prostate cancer by reducing androgen receptor activity.

Dual-targeted therapy is effective and safe for difficult-to-treat inflammatory bowel disease.

Certain liver diseases respond well to specific treatments and have varying risks for liver cancer.

Pimecrolimus reduces the effectiveness of stem cell therapy for atopic dermatitis.

CGF therapy may help hair regrowth and improve scars in DLE patients.

The combined treatment helped prevent hair loss and promoted full hair regrowth in breast cancer patients after chemotherapy.

Combining hydroxychloroquine and pimecrolimus can effectively treat hair loss from discoid lupus.

Chemotherapy improved a girl's painful foot condition linked to pachyonychia congenita.

A young woman with severe symptoms of CPAN improved with intensive treatment but needed a leg amputation.

A new carrier improves skin delivery of tofacitinib for treating inflammatory skin diseases.

IP-PA1 helps grow hair in mice and affects human cell growth-related genes differently than traditional hair growth treatments.

Scalp cooling significantly reduces hair loss in chemotherapy patients.

Researchers made a cell line that grows quickly and can help with hair growth research.

Researchers created immortal human skin cells with constant testosterone receptor activity to study hair loss and test treatments.

The study created special nanoparticles that effectively deliver an anti-inflammatory drug to treat skin inflammation in psoriasis.

Using CDK inhibitors on rats showed a reduction in chemotherapy-caused hair loss, but later experiments could not repeat these results.

PDE inhibitors, especially PDE4 inhibitors like apremilast, are effective for certain inflammatory skin conditions but have side effects and can be costly.

Silicate-based therapy may help treat inflammatory heart disease by reducing immune inflammation.

PX-12 may help treat psoriasis by blocking inflammation and cell death.

A new test helps find drugs to treat head and neck cancer by targeting c-Rel.